Rx (Prescription Medicine)
阿扎定 150毫克 注射液用于治疗某些类型的血液癌症，包括骨髓增生异常综合征和急性髓系白血病。本品由医疗专业人员给药，且只能在医疗监督下使用。
阿扎定 150毫克 注射液是一种含有活性成分阿扎胞苷的药物产品。阿扎胞苷是一种去甲基化剂，用于治疗某些类型的癌症，主要是骨髓增生异常综合征 (MDS) 和急性髓系白血病 (AML)。它通过改变癌细胞中的DNA和蛋白质发挥作用，有助于减缓或阻止其生长并诱导细胞死亡。阿扎定 150毫克 注射液由医疗专业人员通过注射给药。务必遵循医生关于剂量和给药的指示。请勿自行给药。重要注意事项包括告知医生任何既往病史，特别是肾脏或肝脏问题，以及您正在服用的任何其他药物。本药物可能引起副作用，务必向您的医疗保健提供者报告任何异常症状。按照您的医疗保健提供者的指示储存阿扎定 150毫克 注射液，通常在室温下并避光保存。
| Medicine Form | |
|---|---|
| Rx Status | |
| Medicine Type | |
| Molecule | |
| Strength | |
| Brand Name | |
| Molecule | |
| Strength | 150 Mg |
| Medicine Form | Injection |
| Pack Quantity | 1 Vial |
| Packaging Type | Vial |
| Medicine Type | Generic |
| Country Of Origin | India |
| Rx Status | Rx (Prescription Medicine) |
未库存此 exact 强度的其他品牌，因此这些是其他强度的 Azacitidine. 未经开方医生建议，请勿更改剂量。
医学审核
Renu Meena, B.Pharm
Medical Content Writer
Renu Meena is an experienced Medical Content Writer with a strong foundation in pharmacy practice. She holds a Bachelor of Pharmacy (B.Pharm) degree from Rajasthan University of Health Sciences (RUHS), Jaipur, and is registered with the Rajasthan State Pharmacy Council (Reg. No. 55661). With 4+ years of experience across clinical pharmacy and medical content development, she creates evidence-based content for medicines, diseases, and patient education. Her work is shaped by a strong understanding of pharmacovigilance and regulatory standards, including ICH guidelines, GVP modules, ICD-10/11, and safety reporting requirements. Renu focuses on making complex medical information simple, accurate, and useful for readers while maintaining high quality and compliance.
